RAC 5.44% $1.65 race oncology ltd

Mason welcome back. I hope you are rested and refreshed.I agree...

  1. 8,382 Posts.
    lightbulb Created with Sketch. 1382
    Mason welcome back. I hope you are rested and refreshed.

    I agree 99%. BP want to see the whole process including CDx in action.

    I don't agree with "We know Zantrene requires a specific patient population". We have a hypothesis that Zantrene will be most effective against cancers with over-expressed FTO. But we don't know that Zantrene will be useless in other cases. Maybe it will be less effective, but better than nothing.
    So that could be an interesting outcome of throwing darts blindfolded.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.